Premature ovarian failure

Srpski Arhiv za Celokupno Lekarstvo

Volumn 140, Issue 11-12, 2012, Pages 806-811

  Vujović, Svetlana ^a,b   Ivović, Miomira ^b   Tančić Gajić, Milina ^b   Marina, Ljiljana ^b   Barać, Marija ^b   Arizanović, Zorana ^b   Nenezić, Ana ^b   Ivanisević, Maja ^b   Micić, Jelena ^b   Sajić, Silvija ^a,c   Micić, Dragan ^a,b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c UNIVERSITY CHILDREN S HOSPITAL   (Serbia)

Author keywords

Etiology; Premature ovarian failure; Therapy

Indexed keywords

ARTICLE; FEMALE; HUMAN; PREMATURE OVARIAN FAILURE;

FEMALE; HUMANS; PRIMARY OVARIAN INSUFFICIENCY;

EID: 84873151677     PISSN: 03708179     EISSN: None     Source Type: Journal    
DOI: 10.2298/SARH1212806V     Document Type: Article

References (35)

1. Coulam CB, Adamson CE, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67:604-6. (Pubitemid 16116286)
2. Conway GS. Clinical manifestations of genetic defects affecting gonadotrophins and their receptors. Clin Endocrinol (Oxf). 1996;45(6):657-63. (Pubitemid 27032310)
3. Van Kesteren YM, Hundscheid RD, Smits AP, Cremers FP, Van Zonneveld P, Braat DD. Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease? Hum Reprod. 1999;14:2455-9. (Pubitemid 29473910)
4. Vujovic S. Aetiology of premature ovarian failure. Menopause International. 2009;15:72-5.
5. Schlessinger D, Herrera L, Mumm S, Percesepe A, Pellegrini M, Pilia G. Genes and translocations involved in premature ovarian failure. Am J Med Genet. 2002;111(3):328-33. (Pubitemid 34815460)
6. Loughlin SA, Redha A, McIver J, Boyd E, Carothers A, Connor JM. Analysis of the origin of Turner syndrome using polymorphic DNA probes. J Med Genet. 1991;28:156-8. (Pubitemid 21922574)
7. Ogata T, Matsuo N. Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features. Hum Genet. 1995;95:607-29.
8. Jacobs P, Baikie AG, Brown WM, MacGregor TN, Maclean N, Harnden DG. Evidence for the existence of the human super female. Lancet. 1959;274:423-5.
9. Goswami R, Goswami D, Kabra M, Gupta N, Dubey S, Dadhwal V. Prevalence of the triple X syndrome in phenotypically normal women with premature ovarian failure and its association with autoimmune thyroid disorders. Fertil Steril. 2003;80:1052-4. (Pubitemid 37230048)
10. Simpson JL, Rajkovic A. Ovarian differentiation and gonadal failure. Am J Med Genet. 1999;89:186-200. (Pubitemid 30180704)
11. Merry DE, Lesko JG, Sosnoski DM, Lewis RA, Lubinsky M, Trask B, et al. Choroideremia and deafness with stapes fixation: a contiguous gene deletion syndrome in Xq21. Am J Hum Genet. 1989;45:530-40. (Pubitemid 19261440)
12. Sarto GE, Therman E, Pataw K. X inactivation in man: a woman with t (Xq-12q+) Am J Hum Genet. 1973;25:262-70.
13. Therman E, Laxova R, Susman B. The critical region on the human Xq. Hum Genet. 1990;85:455-61.
14. Tharapel AT, Anderson KP, Simpson JL, Martens PR, Wilroy RS, Schwartz CE. Deletion (X) (q26.1-128) in proband and her mother: molecular characterization and phenotypic karyotypic deductions. Am J Hum Genet. 1993;52:463-71. (Pubitemid 23311316)
15. Powell CM, Taggart RT, Drumheller TC, Wangsa D, Quian C, Nelson LM, et al. Molecular and cytogenetic studies of an X: autosome translocations in patients with premature ovarian failure and review of the literature. Am J Med Genet. 1994;52:19-26. (Pubitemid 24237325)
16. Marozzi A, Testa G, Cinelli E, Menevri R, Dal Pra. Association between idiopathic premature ovarian failure and fragile X mutation. Hum Reprod. 2000;15(1):197-202. (Pubitemid 30035123)
17. Waggoner DD, Buist NR, Donnell GN. Long-term prognosis in galactosaeia: results of a survey of 350 cases. J Inherit Metab Dis. 1990;13:802-18.
18. Forges T, Monnier-Barbarino P. Premature ovarian failure in galactosaemia: patophysiology and clinical management. Pathol Biol. 2003;51-47:56.
19. Conway GS. Premature ovrian failure. Br Med Bull. 2000;56:643-9.
20. Hoek A, Schomaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Review. 1997;18(1):107-34. (Pubitemid 27076457)
21. Yan G, Schoenfield D, Penney C, Hurxthal K, Taylor AE, Faustamn D. Identification of premature ovarian failure patients with underlying autoimmunity. J Womens Health Gend Based Med. 2000;9:275-87. (Pubitemid 30234952)
22. Wang CY, Davoodi-Semiromi A, Huang W, Connor E, Shi JD, She JX. Characterization of mutations in patients with autoimmune polyglandular syndrome type I (APS1). Hum Genet. 1998;103:681-5. (Pubitemid 29020764)
23. Bakalov VK, Vanderhoof UH, Bondy CA, Nelson LM. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure Hum Reprod. 2002;17(8):2096-100.
24. Amato P, Roberts AC. Transient ovarian failure: a complication of uterine artery embolization. Fertil Steril. 2001;75:438-9. (Pubitemid 32112128)
25. Goswami D, Conway GS. Premature ovarian failure. Horm Res. 2007;68:196-202. (Pubitemid 350194933)
26. Oktay K, Sonmezer M, Oktem O, Fox K, Emons G, Bang H. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. Oncologist. 2006;12(9):1055-66. (Pubitemid 350007017)
27. Rees M. Various management strategies for problems encountered during menopause. Menopause Int. 2008;14(3):93.
28. th ed. London: RSM Press; 2009.
29. Vujovic S, Brincat M, Erel T, Gambacciani M, Lambrinoudaki I, Moen MH, et al. EMAS position statement: Management women with premature ovarian failure. Maturitas. 2010;67:91-3.
30. Vujovic S, Stojanovic M, Penezic Z, Ivovic M, Ivanisevic M, Barac B, et al. Endocrine and metabolic characteristics of women with premature ovarian failure. CIC international, Roma. 2005;757-60.
31. Vujovic S, Ivovic M, Tancic-Gajic M, Marina Lj, Barac M, Arizanovic Z, et al. Prezgodnja odpoved jajcnikov. Med Razgl. 2012;51:S3:69-76.
32. Kingsberg S. Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women. J Sex Med. 2007;3:227-34. (Pubitemid 46372031)
33. Faculty of Family Planning and Reproductive Health Care. Clinical Effectiveness Unit. Contraception for women aged over 40 years. J Fam Plann Reprod Health Care. 2005;31:51-64.
34. Schenck-Gustaffson K, Brincat M, Erel T, Gambacciani M, Lamberdounaki L. Tremorrlieres F, et al. EMAS position statement: managing the menopause in the context of coronary heart disease. Maturitas. 2011;68:94-7.
35. Beljic T, Zivkovic T, Vuksanovic M, Andjelic-Jelic M, Stojanovic J, Buric B, et al. Obesity and metabolic syndrome during the menopausal transition. Climacteric. 2011;14:643-648.